NCT05243238View on ClinicalTrials.gov

Hesperidin and Diosmin Effect on Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

November 12, 2021

Conditions
Metabolic Syndrome and Diabetic Neuropathy
Interventions
DIETARY_SUPPLEMENT

dietary supplement flavonoids

patients were allocated to receive either hesperidin, diosmin, or combination of both and the fourth group was assigned as a control group without intervention

Trial Locations (1)

13556

University, Al Fayyum

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT05243238 - Hesperidin and Diosmin Effect on Metabolic Syndrome | Biotech Hunter | Biotech Hunter